Bisphosphonate Osteonecrosis in a Case of Langerhans Cell Histiocytosis: Report of a Case and Review of Literature

被引:0
作者
Rajkumar, K. [1 ]
Viswambaran, M. [2 ]
Sen, Arijit [3 ]
Chattopadhyay, P. K. [4 ]
机构
[1] Air Force Inst Dent Sci, Oral & Maxillofacial Surg, Agram Post, Bangalore 560007, Karnataka, India
[2] Air Force Inst Dent Sci, AFIDS & Dent Adviser Air, Agram Post, Bangalore 560007, Karnataka, India
[3] Command Hosp AF, Pathol & Lab Sci, Bangalore, Karnataka, India
[4] MEG, Mil Dent Ctr, Bangalore, Karnataka, India
关键词
Langerhans cell histiocytosis; Bisphosphonate osteonecrosis; RISK-FACTORS; ZOLEDRONIC ACID; BONE; JAW; LESIONS; PAMIDRONATE; PREVENTION; MANAGEMENT; MUTATIONS;
D O I
10.1007/s12663-021-01625-x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Langerhans Cell histiocytosis is a rare multisystem disease originating from dendritic cell lines primarily characterized by osteolytic lesion of the skeleton. Chemotherapy along with bisphosphonates have been used to control the progression of the disease and prevent the osteolysis associated with the disease. Bisphosphonate osteonecrosis of the jaws is a common finding following treatment with bisphosphonates for osteoporosis, metastatic tumors to the bone or the osteolytic lesions of multiple myeloma. The article highlights a rare case of bisphosphonate osteonecrosis of the mandible in a case of long-standing Langerhans cell histiocytosis.
引用
收藏
页码:1001 / 1006
页数:6
相关论文
共 31 条
[1]   Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition [J].
Abla, Oussama ;
Weitzman, Sheila .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, :565-570
[2]   Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells [J].
Allen, Carl E. ;
Li, Liunan ;
Peters, Tricia L. ;
Leung, Hon-Chiu Eastwood ;
Yu, Alexander ;
Man, Tsz-Kwong ;
Gurusiddappa, Sivashankarappa ;
Phillips, Michelle T. ;
Hicks, M. John ;
Gaikwad, Amos ;
Merad, Miriam ;
McClain, Kenneth L. .
JOURNAL OF IMMUNOLOGY, 2010, 184 (08) :4557-4567
[3]   Cancer Treatment Dosing Regimens of Zoledronic Acid Result in Near-Complete Suppression of Mandible Intracortical Bone Remodeling in Beagle Dogs [J].
Allen, Matthew R. ;
Kubek, Daniel I. ;
Burr, David B. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) :98-105
[4]   Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis [J].
Arzoo, K ;
Sadeghi, S ;
Pullarkat, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :225-225
[5]   Recurrent BRAF mutations in Langerhans cell histiocytosis [J].
Badalian-Very, Gayane ;
Vergilio, Jo-Anne ;
Degar, Barbara A. ;
MacConaill, Laura E. ;
Brandner, Barbara ;
Calicchio, Monica L. ;
Kuo, Frank C. ;
Ligon, Azra H. ;
Stevenson, Kristen E. ;
Kehoe, Sarah M. ;
Garraway, Levi A. ;
Hahn, William C. ;
Meyerson, Matthew ;
Fleming, Mark D. ;
Rollins, Barrett J. .
BLOOD, 2010, 116 (11) :1919-1923
[6]  
Baim S, 2009, J BONE MINER RES, V24, P561, DOI [10.1359/JBMR.090203, 10.1359/jbmr.090203]
[7]   High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis [J].
Brown, Noah A. ;
Furtado, Larissa V. ;
Betz, Bryan L. ;
Kiel, Mark J. ;
Weigelin, Helmut C. ;
Lim, Megan S. ;
Elenitoba-Johnson, Kojo S. J. .
BLOOD, 2014, 124 (10) :1655-1658
[8]   Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series [J].
Chellapandian, Deepak ;
Makras, Polyzois ;
Kaltsas, Gregory ;
van den Bos, Cor ;
Naccache, Lamia ;
Rampal, Raajit ;
Carret, Anne-Sophie ;
Weitzman, Sheila ;
Egeler, R. Maarten ;
Abla, Oussama .
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
[9]   Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis [J].
da Costa, CET ;
Annels, NE ;
Faaij, CMJM ;
Forsyth, RG ;
Hogendoorn, PCW ;
Egeler, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :687-693
[10]  
Dimitrakopoulos I, 2006, INT J ORAL MAX SURG, V35, P588, DOI 10.1016/j.ijom.2006.02.022